Case Report: A case of multisystem inflammatory syndrome in an 11-year-old female after COVID-19 inactivated vaccine

BackgroundMultisystem inflammatory syndrome in children (MIS-C), also known as pediatric inflammatory, multisystem syndrome temporally associated with SARS-CoV-2, is a rare but serious complication of SARS-CoV-2 infection in children that typically occurs 2–6 weeks after SARS-CoV-2 infection. The pa...

Full description

Bibliographic Details
Main Authors: Saboor Saeed, Jianqing Cao, Jinjiao Xu, Yi Zhang, Xuyang Zheng, Liya Jiang, Chunming Jiang, Xinjuan Zhang
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-02-01
Series:Frontiers in Pediatrics
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fped.2023.1068301/full
_version_ 1811164171553734656
author Saboor Saeed
Saboor Saeed
Jianqing Cao
Jinjiao Xu
Yi Zhang
Xuyang Zheng
Liya Jiang
Chunming Jiang
Chunming Jiang
Xinjuan Zhang
Xinjuan Zhang
author_facet Saboor Saeed
Saboor Saeed
Jianqing Cao
Jinjiao Xu
Yi Zhang
Xuyang Zheng
Liya Jiang
Chunming Jiang
Chunming Jiang
Xinjuan Zhang
Xinjuan Zhang
author_sort Saboor Saeed
collection DOAJ
description BackgroundMultisystem inflammatory syndrome in children (MIS-C), also known as pediatric inflammatory, multisystem syndrome temporally associated with SARS-CoV-2, is a rare but serious complication of SARS-CoV-2 infection in children that typically occurs 2–6 weeks after SARS-CoV-2 infection. The pathophysiology of MIS-C is unknown. MIS-C, first recognized in April 2020, is characterized by fever, systemic inflammation, and multi-system organ involvement. Post-vaccination adverse effects have increased with COVID-19 vaccinations, and MIS linked to immunization with COVID-19 vaccines has also been observed.Case ReportAn 11-year-old Chinese girl presented with a high-grade fever, rash, and dry cough for 2 days. She had her 2nd SARS-CoV-2 inactivated vaccination dose five days before hospital admission. On day 3 & 4, she experienced bilateral conjunctivitis, hypotension (66/47 mmHg), and a high CRP level. She was diagnosed with MIS-C. The patient's condition deteriorated rapidly, necessitating intensive care unit admission. The patient's symptoms improved after intravenous immunoglobulin, methylprednisolone, and oral aspirin therapy. She was discharged from the hospital after 16 days as her general condition, and laboratory biomarkers returned to normal.ConclusionInactivated Covid-19 vaccination might trigger MIS-C. Further research is needed to evaluate whether a correlation exists between COVID-19 vaccination and MIS-C development.
first_indexed 2024-04-10T15:17:05Z
format Article
id doaj.art-498e572ea5a24d7fba8f520f7381c394
institution Directory Open Access Journal
issn 2296-2360
language English
last_indexed 2024-04-10T15:17:05Z
publishDate 2023-02-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Pediatrics
spelling doaj.art-498e572ea5a24d7fba8f520f7381c3942023-02-14T19:07:51ZengFrontiers Media S.A.Frontiers in Pediatrics2296-23602023-02-011110.3389/fped.2023.10683011068301Case Report: A case of multisystem inflammatory syndrome in an 11-year-old female after COVID-19 inactivated vaccineSaboor Saeed0Saboor Saeed1Jianqing Cao2Jinjiao Xu3Yi Zhang4Xuyang Zheng5Liya Jiang6Chunming Jiang7Chunming Jiang8Xinjuan Zhang9Xinjuan Zhang10Department of Pediatrics, International Education College of Zhejiang Chinese Medical University, Hangzhou, Zhejiang, ChinaDepartment of Pediatrics, Affiliated Hangzhou First People's Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, ChinaDepartment of Pediatrics, The Fourth School of Clinical Medicine, Zhejiang Chinese Medical University, Hangzhou, Zhejiang, ChinaDepartment of Pediatrics, The Fourth School of Clinical Medicine, Zhejiang Chinese Medical University, Hangzhou, Zhejiang, ChinaDepartment of Pediatrics, Affiliated Hangzhou First People's Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, ChinaDepartment of Pediatrics, Affiliated Hangzhou First People's Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, ChinaDepartment of Pediatrics, Affiliated Hangzhou First People's Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, ChinaDepartment of Pediatrics, Affiliated Hangzhou First People's Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, ChinaDepartment of Pediatrics, The Fourth School of Clinical Medicine, Zhejiang Chinese Medical University, Hangzhou, Zhejiang, ChinaDepartment of Pediatrics, Affiliated Hangzhou First People's Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, ChinaDepartment of Pediatrics, The Fourth School of Clinical Medicine, Zhejiang Chinese Medical University, Hangzhou, Zhejiang, ChinaBackgroundMultisystem inflammatory syndrome in children (MIS-C), also known as pediatric inflammatory, multisystem syndrome temporally associated with SARS-CoV-2, is a rare but serious complication of SARS-CoV-2 infection in children that typically occurs 2–6 weeks after SARS-CoV-2 infection. The pathophysiology of MIS-C is unknown. MIS-C, first recognized in April 2020, is characterized by fever, systemic inflammation, and multi-system organ involvement. Post-vaccination adverse effects have increased with COVID-19 vaccinations, and MIS linked to immunization with COVID-19 vaccines has also been observed.Case ReportAn 11-year-old Chinese girl presented with a high-grade fever, rash, and dry cough for 2 days. She had her 2nd SARS-CoV-2 inactivated vaccination dose five days before hospital admission. On day 3 & 4, she experienced bilateral conjunctivitis, hypotension (66/47 mmHg), and a high CRP level. She was diagnosed with MIS-C. The patient's condition deteriorated rapidly, necessitating intensive care unit admission. The patient's symptoms improved after intravenous immunoglobulin, methylprednisolone, and oral aspirin therapy. She was discharged from the hospital after 16 days as her general condition, and laboratory biomarkers returned to normal.ConclusionInactivated Covid-19 vaccination might trigger MIS-C. Further research is needed to evaluate whether a correlation exists between COVID-19 vaccination and MIS-C development.https://www.frontiersin.org/articles/10.3389/fped.2023.1068301/fullSARS-CoV2covid-19 inactivated vaccinemultisystem inflammatory syndromemethylprednisolonecoronavirus disease 2019 (COVID-19)
spellingShingle Saboor Saeed
Saboor Saeed
Jianqing Cao
Jinjiao Xu
Yi Zhang
Xuyang Zheng
Liya Jiang
Chunming Jiang
Chunming Jiang
Xinjuan Zhang
Xinjuan Zhang
Case Report: A case of multisystem inflammatory syndrome in an 11-year-old female after COVID-19 inactivated vaccine
Frontiers in Pediatrics
SARS-CoV2
covid-19 inactivated vaccine
multisystem inflammatory syndrome
methylprednisolone
coronavirus disease 2019 (COVID-19)
title Case Report: A case of multisystem inflammatory syndrome in an 11-year-old female after COVID-19 inactivated vaccine
title_full Case Report: A case of multisystem inflammatory syndrome in an 11-year-old female after COVID-19 inactivated vaccine
title_fullStr Case Report: A case of multisystem inflammatory syndrome in an 11-year-old female after COVID-19 inactivated vaccine
title_full_unstemmed Case Report: A case of multisystem inflammatory syndrome in an 11-year-old female after COVID-19 inactivated vaccine
title_short Case Report: A case of multisystem inflammatory syndrome in an 11-year-old female after COVID-19 inactivated vaccine
title_sort case report a case of multisystem inflammatory syndrome in an 11 year old female after covid 19 inactivated vaccine
topic SARS-CoV2
covid-19 inactivated vaccine
multisystem inflammatory syndrome
methylprednisolone
coronavirus disease 2019 (COVID-19)
url https://www.frontiersin.org/articles/10.3389/fped.2023.1068301/full
work_keys_str_mv AT saboorsaeed casereportacaseofmultisysteminflammatorysyndromeinan11yearoldfemaleaftercovid19inactivatedvaccine
AT saboorsaeed casereportacaseofmultisysteminflammatorysyndromeinan11yearoldfemaleaftercovid19inactivatedvaccine
AT jianqingcao casereportacaseofmultisysteminflammatorysyndromeinan11yearoldfemaleaftercovid19inactivatedvaccine
AT jinjiaoxu casereportacaseofmultisysteminflammatorysyndromeinan11yearoldfemaleaftercovid19inactivatedvaccine
AT yizhang casereportacaseofmultisysteminflammatorysyndromeinan11yearoldfemaleaftercovid19inactivatedvaccine
AT xuyangzheng casereportacaseofmultisysteminflammatorysyndromeinan11yearoldfemaleaftercovid19inactivatedvaccine
AT liyajiang casereportacaseofmultisysteminflammatorysyndromeinan11yearoldfemaleaftercovid19inactivatedvaccine
AT chunmingjiang casereportacaseofmultisysteminflammatorysyndromeinan11yearoldfemaleaftercovid19inactivatedvaccine
AT chunmingjiang casereportacaseofmultisysteminflammatorysyndromeinan11yearoldfemaleaftercovid19inactivatedvaccine
AT xinjuanzhang casereportacaseofmultisysteminflammatorysyndromeinan11yearoldfemaleaftercovid19inactivatedvaccine
AT xinjuanzhang casereportacaseofmultisysteminflammatorysyndromeinan11yearoldfemaleaftercovid19inactivatedvaccine